Gene expression profiling for predicting the survivability of prostate cancer subjects

Details for Australian Patent Application No. 2009268659 (hide)

Owner Source Precision Medicine, Inc.

Inventors Wassmann, Karl; Storm, Kathleen; Siconolfi, Lisa; Bankaitis-Davis, Danute

Agent Cullens

Pub. Number AU-A-2009268659

PCT Pub. Number WO2010/006048

Priority 61/135,007 15.07.08 US; 61/134,208 08.07.08 US; 61/191,688 10.09.08 US

Filing date 8 July 2009

Wipo publication date 14 January 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/006048 Priority application(s): WO2010/006048

19 July 2012 Assignment before Grant

  Source Precision Medicine, Inc. The application has been assigned to Genomic Health, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268662-Gradient compression hosiery knitted using corespun yarns

2009268649-Thermal energy storage container